English
43rd Annual J.P. Morgan Healthcare Conference
Andreas Segerros, CEO at Sylentis, will be representing our team at the conference
Loading view.
6th RNAi-Based Therapeutics Summit
Sylentis sponsor as Innovation Partner
First General Assembly and Annual Conference of the IPCEI Med4Cure
Ministère de l'Economie, des Finances, de la Souveraineté industrielle et numérique 139 rue de Bercy, Paris, FranceLeveraging RNA-based production processes: European models of innovation (17:00-17:45h) Ana Isabel Jiménez, Managing Director de Sylentis,
ARVO 2025
Salt Lake City, Utah Salt Lake City, UT, United StatesTides EEUU 2025
San Diego, USA San Diego, CA, United StatesStand: 212 Asistentes: Lola Company y Pablo Lores Lareo
Conferencia Internacional de Oligonucleótidos y Péptidos 2025
Praga Prague, Czech RepublicAsistente: Pablo Lores Lareo
Farmaforum 2025
Madrid Av. del Partenón, 5 , Barajas, Madrid, Spain
Reunión de la Sociedad de Terapéutica de Oligonucleótidos 2025
Budapest Budapest, HungaryAsistentes: Lola Company y Pablo Lores Lareo
TIDES UE 2025
Basel Basel, SwitzerlandAsistente: Pablo Lores Lareo
Jornada informativa IPCEI Salud MED4CURE
Dónde: Sala Multiusos del CDTI (C/ Cid, 4 - Madrid) Contacto: comunicacion@cdti.es
